Key statistics
On Monday, ACADIA Pharmaceuticals Inc (ACAD:NSQ) closed at 14.73, 1.24% above its 52-week low of 14.55, set on Jun 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.14 |
---|---|
High | 15.14 |
Low | 14.60 |
Bid | 14.69 |
Offer | 14.98 |
Previous close | 15.10 |
Average volume | 1.79m |
---|---|
Shares outstanding | 165.88m |
Free float | 164.99m |
P/E (TTM) | 83.28 |
Market cap | 2.50bn USD |
EPS (TTM) | 0.1813 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 21:00 BST.
More ▼
Press releases
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
- Ryan Reynolds Announces More to Parkinson’s® Campaign
- Acadia Pharmaceuticals to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview
- Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2024
- Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med
More ▼